Listen to the article
Al Horford Sidelined with Sciatic Nerve Inflammation as Warriors Face Frontcourt Challenge
The Golden State Warriors will be without veteran center Al Horford for at least their next several games as he deals with right sciatic nerve inflammation, adding another complication to the team’s challenging start to the season.
Horford, who has already missed four consecutive games with the injury, briefly returned in Thursday’s loss to the Philadelphia 76ers, where he managed just three points in 18 minutes of action. The 39-year-old forward, Golden State’s most significant free agent acquisition of the offseason, has struggled to make the impact the team had hoped for since his arrival.
Warriors head coach Steve Kerr informed reporters on Sunday that Horford will miss at least three upcoming games: Monday against the Utah Jazz, Wednesday’s NBA Cup matchup with the Houston Rockets, and Saturday’s contest versus the New Orleans Pelicans. This absence leaves the Warriors particularly vulnerable in the frontcourt during a crucial stretch of games.
The timing couldn’t be worse for Golden State, which has slipped below .500 following Thursday’s disappointing loss to Philadelphia. While the organization recruited Horford primarily for his potential playoff impact, his regular season contributions have fallen well short of expectations.
Through his appearances this season, Horford is averaging just 5.8 points on 34.4% shooting from the field and 32% from three-point range, along with 4.3 rebounds and 1.8 assists in 21.8 minutes per game. These numbers represent a significant decline from his previous production during four successful seasons with the Boston Celtics.
Complicating matters further for the Warriors, defensive anchor Draymond Green is questionable for Saturday’s game against the Cleveland Cavaliers with a foot injury. Without their two most experienced frontcourt players, Golden State will likely turn to younger big men Quinten Post and Trayce Jackson-Davis to fill the void.
In his last full appearance before the extended absence, Horford played 18 minutes off the bench against the Portland Trail Blazers, contributing seven points on 2-of-5 shooting while adding six rebounds and three assists in a narrow 127-123 defeat.
The five-time NBA All-Star and 2022 champion with the Celtics joined the Warriors this past offseason, teaming up with Stephen Curry in what was hoped to be a seamless integration of veteran leadership and championship experience. Entering his 19th NBA season, Horford was expected to provide stability, floor spacing, and defensive intelligence to a Warriors team looking to return to championship contention.
Instead, injuries and inconsistent play have marked his tenure thus far. The sciatic nerve issue represents a particularly concerning development, as such injuries can be notoriously difficult to manage and often require extended recovery periods, especially for older players.
For the Warriors, Horford’s absence highlights their continued struggles to find consistency in their frontcourt rotation. The team now faces additional pressure during an already challenging stretch of their schedule, with increased responsibility falling to their younger, less experienced big men.
While Horford is expected to be available for Sunday’s game against the Chicago Bulls, the second night of a back-to-back, the Warriors’ medical staff will likely proceed with caution given the nature of his injury and his importance to the team’s long-term plans this season.
As Golden State navigates this difficult period, management and fans alike will hope for Horford’s swift recovery and eventual return to form, recognizing that his veteran presence could still prove valuable as the season progresses toward the playoffs.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.


31 Comments
Interesting update on Fact Check: Reports of Al Horford’s NBA Career Ending Due to Health Issues Are Unfounded. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Production mix shifting toward Fact Check might help margins if metals stay firm.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Production mix shifting toward Fact Check might help margins if metals stay firm.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Silver leverage is strong here; beta cuts both ways though.
Production mix shifting toward Fact Check might help margins if metals stay firm.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on Fact Check: Reports of Al Horford’s NBA Career Ending Due to Health Issues Are Unfounded. Curious how the grades will trend next quarter.